Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
苏州润迈德医疗科技有限公司 logo — Pioneering the future of vascular interventional surgery wit...

苏州润迈德医疗科技有限公司

Pioneering the future of vascular interventional surgery with our advanced coronary angiography systems

Founded 2014 10 employees Series D Total: $100.00M Health Care, Medical Devices +1

General Information

Company Name 苏州润迈德医疗科技有限公司
Founded Year 2014
Employees 10
Industries Health Care, Medical Devices, Robotics
Funding Stage Series D
Social

BounceWatch is an independent company data service, not affiliated with 苏州润迈德医疗科技有限公司. To contact 苏州润迈德医疗科技有限公司, visit rainmed.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About 苏州润迈德医疗科技有限公司

Rain Med is a pioneering startup dedicated to advancing the field of vascular interventional surgery through the development of cutting-edge coronary angiography systems. Established in 2014, the company operates within the Health Care and Robotics industries. Notably, Rain Med recently secured a significant $100.00M Series D investment on 01 December 2021 from Ping An Capital, signifying strong investor confidence in the company's innovative technological advancements. With its focus on revolutionizing vascular interventional surgical robotics, Rain Med is poised to make a significant impact in the healthcare sector and beyond.

Taxonomy: vascular interventional surgery, coronary angiography, surgical robots, medical robotics, interventional cardiology

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series D $100.00M 1
Ping An Capital
Ping An Capital
01 Dec 2021

苏州润迈德医疗科技有限公司 Alternatives & Competitors

View All Alternatives
苏州润迈德医疗科技有限公司 vs
Angiodroid
Angiodroid Italy

Automated Carbon Dioxide Angiography with Angiodroid the CO2 Injector

Series A
43 employees
Health Care, Medical Devices
苏州润迈德医疗科技有限公司 vs
Claret Medical
Claret Medical

Pioneering cerebral protection for safer vascular procedures.

Series C
Health Care, Medical Devices
苏州润迈德医疗科技有限公司 vs
Stereotaxis
Stereotaxis United States

Pioneering Endovascular Robotics

Post-IPO Equity
200 employees
Biotechnology, Health Care
View all alternatives

FAQ About 苏州润迈德医疗科技有限公司

Pioneering the future of vascular interventional surgery with our advanced coronary angiography systems
苏州润迈德医疗科技有限公司 was founded in 2014.
苏州润迈德医疗科技有限公司 operates in Health Care, Medical Devices and Robotics. Its work centres on vascular interventional surgery, coronary angiography, surgical robots and medical robotics.
苏州润迈德医疗科技有限公司 has approximately 10 employees.
苏州润迈德医疗科技有限公司 has completed 1 funding round, raising a total of $100.00M. The latest funding stage is Series D.
Top alternatives and competitors to 苏州润迈德医疗科技有限公司 include Angiodroid, Claret Medical, Stereotaxis, Bioabsorbable Therapeutics, Saranas. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
苏州润迈德医疗科技有限公司 and Angiodroid are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for 苏州润迈德医疗科技有限公司, https://bouncewatch.com/company/rain-med, updated 21 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes